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Abstract
Objectives: DNA sequences are very rich in short repeats
and their pattern can be altered by point mutations. We
wanted to investigate the effect of single nucleotide poly-
morphism (SNP) on the pattern of short DNA repeats and
its biological consequences. Methods: Analysis of the
pattern of short DNA repeats of the Thy-1 sequence with
and without SNP. Searching for DNA-binding factors in
any region of significance. Results: Comparing the pat-
tern of short repeats in the Thy-1 gene sequences of Tur-
kish patients with ataxia telangiectasia (AT) with the ‘wild
type’ sequence from the DNA database, we identified a
missing 8-bp repeat element due to an SNP in position
1271 (intron II) in AT-DNA sequences. Only the mutated
sequence had the potential for the formation of a stem
loop in DNA or pre-mRNA. In super-shift experiments we
found that DNA oligomers covering the area of this SNP
formed a complex with proteins amongst which we iden-
tified the proliferating cell nuclear antigen (PCNA) pro-
tein. Conclusion: SNPs have the potential to alter DNA or
pre-mRNA conformation. Although no SNP-depeding
formation of the DNA-protein complex was evident,
future investigations could reveal differential molecular
mechanisms of cellular regulation.
Copyright © 2001 S. Karger AG, Basel
Introduction
The search for mutations in genomic DNA is mostly
restricted to the identification of alterations in the coding
sequence or the regulatory region of genes, which in-
fluence the expression of a phenotype. As a consequence,
mutations in introns and intergenic sequences are rarely
investigated and are mostly viewed as part of the spec-
trum of alterations in the DNA as proposed by the quasi-
species model [1]. About 90% of the human genetic varia-
tion has been ascribed to single nucleotide polymor-
phisms (SNPs), which occur at frequencies of more than
1% [2]. The most important SNPs seem to be the usually
rare non-synonymous mutations, which affect the amino
acid sequence of a gene product and, because of linkage
disequilibrium, can be genetic markers for mutations
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responsible for disease. However, SNPs in non-coding
sequences could interfere with nucleotide correlation [3],
the complexity and secondary struture of DNA and the
mediation of the dynamics of the genome [4].
It had been shown earlier that DNA sequences con-
tained a dense pattern of short repeat elements made of
3–25 bp [5–7], which were shown to stabilize the loop
structures in non-coding sequences of pre-mRNA and to
determine the half-life and expresssion of mRNA [8].
Also, the analysis of radiation-induced HGPRT deletion
mutants revealed that the deleted sequences were flanked
by short direct repeats [9]. Increased dynamics of the
genome have been found in cells from patients suffering
from somatic mutation disease (SMD) [10]. These cells
express increased rates of mutations, sister chromatid
exchanges, translocations and chromosome instability.
Ataxia telangiectasia (AT) is one of the best described
SMDs and is characterized by an increased cancer risk
and, on the cellular level, by hypersensitivity to ionizing
radiation, chromosome instability, hypermutability and a
high rate of intra-chromosomal recombination [for re-
views, see ref. 11, 12].
We hypothesized that these repeat patterns might pos-
sess a function in the stability of the genome, and hence
could provide a signal to link the DNA sequence with the
metabolism of the DNA. Thus, a factor capable of first
binding to DNA and second recruiting DNA-metaboliz-
ing enzymes must be associated with these repeat se-
quences. Amongst the plethora of DNA-binding proteins
the proliferating cell nuclear antigen (PCNA) seemed to
be the one with the greatest potential to fulfil that role.
The ring-shaped homo-trimer structure is capable of en-
circling double-stranded DNA, forming a sliding clamp
[for a review, see ref. 13]. PCNA is an auxiliary protein of
DNA polymerase ‰ [14, 15] and Â [16]. It plays an essen-
tial role in nucleotide excision repair [17] as well as in
DNA replication and DNA synthesis [18]. Protein-pro-
tein interactions have been described with Gadd45 [19],
maturation factor 1 (Fen1) [20], the cyclin-dependent
kinase inhibitor p21WAF1/Cip1 [21], DNA-(cytosin-5) meth-
yltransferase (MCMT) [22] and DNA repair endonu-
clease XPG [23]. Interestingly, homologous regions of
Fen1, p21WAF1/Cip1, MCMT and XPG compete for bind-
ing to the same site on PCNA [24], which could have
immense implications for a regulatory network, linking
these diverse protein functions.
We found that an 8-bp repeat element in the Thy-1
sequence of Turkish AT patients was missing, which was
attributed to a point mutation. The repeat sequence lies in
an area of similarities to repetitive elements and poten-
tially alters the loop structures of single-stranded DNA
and pre-mRNA. Unfortunately, no cells carrying this mu-
tation were available. Hence we were limited to structural
analysis in our search for the biological effects of this
mutation. In super-shift experiments we identified PCNA
complexed with other proteins with double-stranded
DNA oligomers containing the sequence of the 8-bp
repeat element. However, the binding of the protein com-
plex was independent of the confirmation of the DNA.
Materials and Methods
Sequence Analysis
The sequence of Thy-1 [25] was obtained from GENBANK (ac-
cession No. HUMTHY1A) and the mutations identified in AT
patients were communicated by Teraoka [26]. Short sequence re-
peats were identified using an algorithm described ealier [27].
Repeats of less than 8 bp were not analysed. For the analysis of the
hypothetical structure of the single-stranded DNA, the program
‘RNA fold’ [28, 29] was employed.
Cells and Tissue Culture
Mormal primary MRC5 cells, primary AT4BI and AT7, SV40
transformed MRC5BIVA, AT5BIVA (a generous gift from C. Arlett,
Brighton, UK) and GM637, HT29 and atxbc were grown under nor-
mal culture conditions in EMEM medium with Earle’s salts
(Northumbria Biological Ltd, nbl) containing 10% fetal bovine
serum, 0.2 U/ml penicillin and 0.2 Ìg/ml streptomycin.
Preparation of Protein Extracts
4 ! 106 were grown in 75-cm2 flasks, washed twice with ice-cold
PBS, scraped off and transferred to Eppendorff tubes. The cells were
pelleted for 2 min in the cold room and resuspended in 400 Ìl of
buffer A (10 mM HEPES-KOH pH 7.8, 1.5 mM MgCl2, 10 mM KCl,
0.5 mM DTT, 0.2 mM PMSF) and incubated on ice for 10 min. After
the swelling period the cells were spun down for 1 min in a cold room
and resuspended in 50 Ìl of buffer C (20 mM HEPES-KOH pH 7.8,
25% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA,
0.5 mM DTT, 0.2 mM PMSF). High salt extraction was continued
on ice for 20 min before the nuclei were spun down for 2 min in a
cold room, the supernatants transferred into fresh Eppendorff tubes
and stored at –70°C [30].
5)-End-Labelling of DNA Oligomers with T4 Polynucleotide
Kinase
20 pmol of each oligomer were directly phosphorylated using
[Á32P]dATP (Amersham) and a commercial end-labelling kit (Boeh-
ringer). The end-labelled oligomers were ethanol-precipitated,
washed twice with ice-cold 80% ethanol and redissolved in 40 Ìl dou-
ble-distilled water. The efficiency of the labelling process was deter-
mined by counting the cpm of 1 Ìl solution in a United Technologies/
Packard 2000 Series scintillation counter.
For the preparation of double-stranded oligomers, equal quanti-
ties (pmol) of labelled complementary oligomers were mixed, incu-
bated for 10 min at 65°C in a waterbath and allowed to slowly cool
down to room temperature. For storage the double-stranded oligo-
mers were kept at –20 °C.
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Sequences of the DNA oligomers: thy001 (position 1265–1289):
GAG ACC AGG CTG TTC CTG GTC CCA G; thy002 (position
1289–1265): CTG GGA CCA GGA ACA GCC TGG TCT C; thy003
(position 1253–1276): GGC TGG TTC TGT GAG ACC AGG
CTG; thy004 (position 1276–1253): CAG CCT GGT CTC ACA
GAA CCA GCC; thy005 (position 1265–1289): GAG ACC GGG
CTG TTC CTG GTC CCA G; thy006 (position 1289–1265): CTG
GGA CCA GGA ACA GCC CGG TCT C; thy007 (position 1253–
1276): GGC TGG TTC TGT GAG ACC GGG CTG; thy008 (posi-
tion 1276–1253): CAG CCC GGT CTC ACA GAA CCA GCC; ran-
dom oligomer (double-stranded DNA): TGT TCC GAA TGG CCA
ACA TTC ACT CCT.
Gel Retardation Assay
If not indicated otherwise, 2 Ìl of the protein extract, 10 Ìl of 2 !
buffer B (20 mM HEPES-KOH pH 7.8, 10 mM MgCl2, 2 mM
EDTA, 2 mM DTT, 10% glycerol), 2 Ìl dI-dC (1 Ìg/Ìl, Boehringer),
4 Ìl sterile double-distilled water and 2 Ìl of labelled double-
stranded oligomer were mixed and incubated for 35 min at 22°C.
Following the incubation period the samples and 1 Ìl of 2 ! loading
buffer were applied to a 0.5 ! TBE, 3.7% polyacrylamide gel (19:1
mono- to bis-acrylamide) and electrophoresed with 150 V until the
dye front and free oligomers migrated out of the gel. The gels were
vacuum-dried and autoradiographed [31].
For super-shift experiments, 2 Ìl of the protein extract, 10 Ìl of
2 ! buffer B, 2 Ìl of dI-dC and 2 Ìl of double-distilled water were
incubated on ice with 2 Ìl of antibody solution (PCNA antibody
PC10 from DAKO A/S, Denmark, or control antibodies) for 45 min.
Thereafter the labelled oligomers were added and the mix kept on ice
for another 10 min. Only then the samples were incubated at 22°C
for 35 min and processed as described for band shift experiments.
DNA Preparation and SSCP Analysis
Genomic DNA was extracted using standard protocols. Amplifi-
cation of the Thy-1 sequences flanking the polymorphism at position
1271 was achieved in polymerase chain reactions (PCR) employing
primers thy1b (position 1181–1201, TCA TGA TGT TTA GTA
AGG TT) and thy1c (reverse complementary, position 1370–1351,
AAG ACG GAT CAG GAC TCA GG). DNA amplification was per-
formed in a total volume of 10 Ìl containing 30–50 ng DNA template
in 10 mM Tris-HCl (pH 8), 50 mM KCl, 1.5 mM MgCl2, 100 ÌM of
dCTP, dTTP, dATP, dGTP, 0.5 U Taq-DNA polymerase (Life
Technologies, Karlsruhe, Germany) and 0.3 nmol of each primer.
PCR was based on 36 cycles of 94°C for 45 s, 55°C for 1 min and
71°C for 45 s with an initial denaturation step of 94 °C for 4 min and
a final extension step of 71°C for 7 min. For radioactive labelling
0.3 Ìl alpha-32P-dCTP (3,000 Ci/mM, from Amersham Pharmacia
Biotech) was added. 10 Ìl of each PCR amplification was transferred
into 90 Ìl of dilution buffer (0.1% SDS, 10 mM EDTA), mixed and
6 Ìl thereof added to 6 Ìl of loading buffer (formamide, 0.1% bromo-
phenol blue, 0.1% xylene cyanol, 10 mM EDTA). Finally the samples
were heated to 95°C for 3 min, chilled on ice and loaded onto a
native polyacrylamide gel (5% acrylamide containing 5% glycerol,
0.5 ! TBE). The fragments were separated by electrophoresis in a
standard sequencing apparatus at 12 W for 4 h. Gels were fixed (10%
acetic acid in methanol) for 15 min, dried at 90°C under vacuum
and exposed to X-ray film for up to 3 days.
Results
Analysis of the Pattern of Short DNA Repeat
Sequences
Based on the analysis of 62 Turkish AT individuals
and 35 unaffected individuals 4 point mutations were
previously described in the Thy-1 gene of AT patients:
positions 162 (C to T), 197 (G to A), 240 (G to A) in
intron I and the position 1271 (A to G) in intron II [26,
32]. The ‘wild type’ sequence of the Thy-1 gene was
retrieved from the database (HUMTHY1A) and a copy of
that sequence was amended with the 4 point mutations
identified in AT patients to yield the ‘AT’ sequence of
Thy-1.
Prior to the analysis of sequence patterns, the Thy-1
sequence of the AT patients in 5)–3) orientation was
catenated to its reverse complementary strand, as was the
‘wild type’. Disregarding all repeats of less than 8 bp, a
total of 52 repeats were found in the AT transgene com-
pared to a total of 53 repeats in the control (data not
shown). The excess repeat sequence GACCAGGC (trans-
gene positions 1267–1274 and 4601–4608) from the con-
trol transgene was lost in the AT transgene due to the tran-
sition (A to G) in position 1271. Hence, despite our
restricted pattern analysis (sequence of the repeat had to
be 8 bp or longer), 1 out of 4 SNPs in the Thy-1 gene of
Turkish AT patients had abrogated an inverted repeat.
Figure 1a shows the Thy-1 sequence from the Turkish
AT families from position 1161–1400, which became the
focus of our investigation. When the ‘wild type’ Thy-1
sequences from position 1251 to 1290 were screened
against the database of repetitive sequences (BLASTA
and FASTA programs, HGMP, Cambridge [33]), similar-
ities to sequences of the rodent b1 repetitive sequence (18
out of 24 bp, boxed with dark-grey shading) and to human
Alu repetitive sequences (14 out of 15 bp, boxed with
light-grey shading) were identified. The same analysis per-
formed on the mutant ‘AT’ Thy-1 segment identified no
similarities as the mutation abolished the 8-bp minimal
identity demanded by the algorithm (data not shown).
Analysis of the Potential Secondary Structure of
Thy-1 Sequences
The Thy-1 ‘wild type’ sequences and the mutated
sequence were analysed for their potential to form second-
ary structures using the ‘RNA fold’ program [29]. As
depicted in figure 1b, a triple-loop structure could be
formed starting with position 1244 and extending to posi-
tion 1308 only with the ‘AT’ Thy-1 sequence due to stabil-
isation by 8 G/C base pairs, including G of position 1271
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Fig. 1. Thy-1 sequence from Turkish AT patients and the potential formation of a stem loop.
a Sequence of Thy-1 from AT patients from position 1161 to 1400. Lower-case letters indi-
cate the double-stranded areas of the stem loop. The single nucleotide polymorphism in posi-
tion 1271 found in AT patients (A to G) is indicated in bold. Light shading shows areas of Alu
repeat homology, darker shading homologies to b1 repeats. b Stem loop structures of the
Thy-1 gene from AT patients spanning the sequence from position 910 to 1400 (5)–3) anti-
clockwise). The formation of the most distal loop of the triple loop structure is stabilized by
the A to G mutation in position 1271.
Fig. 2. Gel retardation assay. Nuclear extract from the cell line AT5BIVA (a), and primary cells AT4BI (b) and
MRC5 (c) were incubated with radioactively labelled double-stranded oligomers of the ‘wild-type’ sequence thy001/
thy002 or thy003/thy004 and with the ‘AT’ sequence thy005/thy006 or thy007/thy008. Samples pre-incubated with
the monoclonal antibody PC10 against PCNA are marked (+). The single arrow indicates the position of the band
shifts, the double arrow the position of the super-shifts. Free DNA oligomer was allowed to run off the gel.
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(pairing bases were written in lower case letters in fig-
ure 1a).
Investigations into Factors Binding to DNA Regions
with SNPs
Double-stranded oligomers of the sequence thy001/
thy002, thy003/thy004, thy005/thy006 and thy007/
thy008 were incubated with protein extracts from
AT5BIVA cells (fig. 2a), AT4BI (fig. 2b) and MRC5
(fig. 2c), which resulted in a retardation of the migration
of the oligos, as shown in figure 2, indicated by a single
arrow-head (all lanes –PCNA-Ab). This complex forma-
tion was resistant to the addition of double-stranded
oligomers of random sequence and the migration of the
oligomers with random sequence showed no indication of
retardation following pre-incubation with protein extract
or PCNA antibody. However, addition of a 20-fold excess
of unlabelled thy001/thy002 oligomers to the samples
abolished the signal in the gel retardation assay (fig. 3).
The autoradiographs of band shifts shown in figure 2a
(single arrow; lanes –PCNA-Ab) indicate that the DNA-
binding activity was independent of the ‘wild type’ (oligos
001/002 and 003/004) or ‘AT’ sequence (oligos 005/006
and 007/008). The additional signals found using oligo-
mers 005/006 were most likely due to overexpression of
the gel. However, preliminary experiments revealed that
4 proteins can be found associated with the DNA oligo-
mer (data not shown). Hence, a second explanation for
the additional signals could be that these represent inter-
mediate complexes of proteins and DNA oligomer. In
order to exclude the possibility of proteins binding to
DNA ends as cause for the band shift, we used protein
extracts from cell lines defective in Ku protein (xrs-2 and
xrs-4), which resulted in the same signals as observed
before (data not shown).
PCNA Participates in the DNA Binding Complex
Pre-incubation of nuclear extracts with antibodies
against p53, SV 40-T-antigen, ribonuclease reductase,
DNA polymerase · and cyclin D1 had no effect on the
position of the shifted signal (data not shown). Only pre-
incubation with monoclonal antibody PC10 against
PCNA consistently caused a significant super-shift of the
signal. Figure 2a shows the autoradiographs of band shift
experiments using all 4 double-stranded oligomers and
protein extracts from AT5BIVA cells. Incubation of ex-
tract and oligomer alone (lanes: –PCNA-Ab) showed a
band shift indicated by a single arrow. Pre-incubating
with antibody PC10 against PCNA (lanes: +PCNA-Ab)
produced a high-molecular weight super-shifted signal,
Fig. 3. Gel retardation assay and controls. Protein extract of the cell
line AT5BIVA was incubated with radioactively labelled thy001/
thy002 double-stranded oligo. Retardiation of the migration of the
free oligomer (lane 3) was observed after incubation with protein
extract (lane 2, single arrow) and further retardation was achieved
following the addition of PCNA antibody to the incubation mix (lane
1, super-shift, double arrow). Addition of 20-fold or 50-fold excess of
unlabelled oligomer (lanes 5 and 6, respectively) to the incubation
with protein extract obliterates the band shift signal (lane 4). Addi-
tion of 50-fold excess of a random DNA-oligomer had no influence
on the band shift or the super-shift (lanes 7–9) and the random DNA-
oligomer had no protein-binding capacity (lanes 10–12).
indicated by the double arrow. In addition to the SV40-
transformed cell line AT5BIVA, we also employed the
primary AT4BI cells from an AT patient and MRC5 as
normal control cells. As depicted in figure 2b,c, the band
shift signals using protein extracts of these primary cells
were fainter than those of the transformed cell line
AT5BIVA.
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Fig. 4. SSCP analysis of Thy-1 sequences
harbouring the polymorphism at position
1271. Conformational analysis of PCR-am-
plified DNA: of the cell lines AT7, atxbc,
GM637, HT29, MRC5BIVA (lanes 1–6);
from blood samples from healthy donors; 11,
12, 14, 16, and 20 (lanes 7–11); from frozen
cell samples representing at least 3 years of
continuous culture ATs4,94, ATs4,97 (lanes
12 and 13, respectively), atxbc,94, atxbc,97
(lanes 15 and 16, respectively); from
ATs4neo1, a subclone of ATs4 (lane 14) and
from HT29 (lane 17).
Nevertheless, pre-incubation with PC10 antibody
(+PCNA-Ab) produced a strong super-shifted signal.
Estimation of the Frequency of the Polymorphism at
Position 1271 of Thy-1
A series of cell lines available in our laboratory and
blood samples from 5 healthy volunteers were investi-
gated for the polymorphism at position 1271 of the Thy-1
gene. None of the cell lines AT7 and ATs4 (from patients
with AT, X-ray-sensitive), ATs4-neo1 (G418-resistant
pSV2neo transfectant of ATs4), atxbc [34] (X-ray-resis-
tant derivative of ATs4), GM637 (normal), HT29 (colon
adenoma, mismatch repair deficient), nor the DNA sam-
ples of the 5 volunteers (No. 11, 12, 14, 16 and 20) showed
any indications of a polymorphism in SSCP experiments
(fig. 4). DNA preparations from frozen ATs4 cells with at
least 3 years of permanent culture between them did not
result in the accumulation of the ‘1271’ polymorphism in
the cell population. The same was true for DNA prepara-
tions from two cultures of atxbc cells, one irradiated once
per month with 2 Gy for 3 years and the other cultured in
parallel under normal conditions. This small study sug-
gested that the occurrence of the polymorphism in posi-
tion 1271 of the Thy-1 gene can be expected to be less than
10% of the population, that this locus is resistant to treat-
ment of the cells with mutagens and is stable in cells with
deficient DNA repair mechanisms.
Discussion
The comparison of the Thy-1 DNA sequence from a
family of Turkish AT patients with the normal control
sequence revealed the abrogation of an 8-bp inverse
repeat in the mutated ‘AT’ sequence, caused by the A to G
transition at position 1271. Computer analysis of the
‘wild type’ Thy-1 sequence from position 1251 to 1290
revealed similarities to Alu sequences (position 1253–
1276) and to b1 repetitive elements (position 1265–
1290).
The analysis of the physico-chemical characteristics of
the sequence (910–1,400 bp) revealed the potential for
stem loop formation only in the mutated sequence (G in
position 1271). Such stem loop formation could alter the
processing and transcription rate of pre-mRNA [8] and
hence influence cellular regulatory systems.
Since there were no cells available to investigate the
biological implication of the ‘AT’ mutation, we were lim-
ited to collect evidence of molecular interactions of cellu-
lar factors with this sequence. Hence, two sets of double-
stranded oligomers were designed to cover the region of
interest: mutant ‘AT’ and ‘wild-type’ versions each of the
Alu and b1 similarity regions. Band shift experiments
proved the specific binding of proteins to all oligomers
irrespective of the point mutation in position 1271. Since
the sequence of the Alu set of oligomers overlapped with
the b1 set, the sequence 5)-GAG ACC a/gGG CTG-3) was
common to both types of oligomers. We assumed this to
the binding site for proteins, since controls in our experi-
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ments made it unlikely that certain DNA conformations
or proteins binding to DNA ends were responsible for
binding to the oligomers.
Pre-incubation of protein extracts with antibody to
PCNA caused further retardation of the migration during
gel electrophoresis and hence a super-shift of the oligo-
mers. In accordance with the band shift experiments, the
migration of the DNA-protein complex was not in-
fluenced by the presence of A or G in position 1271 in the
super-shift experiments.
The interaction of PCNA with other proteins in the
regulation of cellular processes is well described. PCNA
recruits DNA polymerases ‰ and Â in cycling cells and dur-
ing DNA repair [35]. If p21WAF1/Cip1 is found complexed
with PCNA, it inhibits DNA synthesis and together with
the inactivation of cyclins by p21 WAF1/Cip1 it synchronizes
the replication of the DNA with the cell cycle [36]. This
regulation could also be assisted by the competitive bind-
ing of Fen1, MCMT, XPG, and p21WAF1/Cip1 for PCNA
[37]. A complex of PCNA and p21WAF1/Cip1 prevents
DNA methyltransferase from methylating GpC islands.
It is conceivable that the functional multiplicity of
PCNA needs multiple determinants for the assembly of
the appropriate protein complex. PCNA exists in the cell
as a stable trimer encircling double-stranded DNA. Such a
PCNA ring contains three potential binding sites for het-
erologous proteins like p21WAF1/Cip1, Fen1, MCMT and
XPG to bind simultaneously and regulate various pro-
cesses of the DNA metabolism [37]. In addition, certain
locations of the DNA in forming a complex with the pro-
tein-PCNA agglomeration could participate in the regula-
tory network. Then, depending on the association of
PCNA with a particular DNA sequence through interac-
tion with a protein complex, PCNA could recruit differ-
ent proteins for differential activities like DNA repair,
DNA replication or DNA methylation. We would like to
suggest that the sequence-specific coexistence of PCNA
together with other proteins might be a prerequisite for its
activity in the replication process as opposed to DNA
repair and methylation. However, it will be necessary to
analyse the conjugating proteins in order to decide which
function a given protein aggregation will assume.
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